共 270 条
[1]
Engel MA(2010)New pathophysiological insights and modern treatment of IBD J Gastroenterol 45 571-583
[2]
Neurath MF(2009)Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon Inflamm Bowel Dis 15 630-638
[3]
Ullman T(2008)Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects Gut 57 1140-1155
[4]
Odze R(2007)The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 12 1424-1429
[5]
Farraye FA(2009)Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies Anticancer Res 29 2727-2737
[6]
Izzo AA(2009)Colorectal cancer surveillance in inflammatory bowel disease: the search continues World J Gastroenterol 15 61-66
[7]
Camilleri M(2006)Interleukin-23 is essential for T cell-mediated colitis and promotes inflammation via interleukin-17 and interleukin 6 J Clin Invest 116 1310-1316
[8]
Kappelman MD(2008)IL-23 and Th17 cytokines in intestinal homeostasis Mucosal Immunol 1 339-349
[9]
Rifas-Shiman SL(2003)Interleukin-10-based therapy for inflammatory bowel disease Expert Opin Biol Ther 3 725-731
[10]
Kleinman K(2004)IL-10 and its related cytokines for treatment of inflammatory bowel disease World J Gastroenterol 10 620-625